Synthesis of Calix-Salen Silver Corates for Evaluation of Their Antimicrobial and Anticancer Activities

por Roy, Hetal, Deolalkar, Mihamee, Desai, Arpita S.
Publicado 2019

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options

por Desai, Arpita, Menon, Smitha P., Dy, Grace K.
Publicado 2016

Synthesis of Novel Bis-imino and Bis-amino Curcuminoids for Evaluation of Their Anticancer and Antibacterial Activity

por Mathur, Priyanka, Mori, Meera, Vyas, Hitarthi, Mor, Kartik, Jagtap, Jalpa, Vadher, Sumita, Vyas, Komal, Devkar, Ranjitsinh, Desai, Arpita
Publicado 2022

Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer

por Borno, Hala T., Kuo Lin, Tracy, Odisho, Anobel Y., Desai, Arpita, Koshkin, Vadim, Werner, Kalin, Legaspi, Nichole, Bucknor, Matthew, Bell, Alexander, Zhang, Sylvia, Hope, Thomas A.
Publicado 2020

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort

por Barata, Pedro, Hatton, Whitley, Desai, Arpita, Koshkin, Vadim, Jaeger, Ellen, Manogue, Charlotte, Cotogno, Patrick, Light, Malcolm, Lewis, Brian, Layton, Jodi, Sartor, Oliver, Basu, Arnab, Kilari, Deepak, Emamekhoo, Hamid, Bilen, Mehmet A.
Publicado 2020

Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer

por Freeman, Meredith N, Jang, Albert, Zhu, Jason, Sanati, Farhad, Nandagopal, Lakshminarayanan, Ravindranathan, Deepak, Desai, Arpita, Phone, Audrey, Nussenzveig, Roberto, Jaeger, Ellen, Caputo, Sydney A, Koshkin, Vadim S, Swami, Umang, Basu, Arnab, Bilen, Mehmet A, Agarwal, Neeraj, Sartor, Oliver, Burgess, Earle F, Barata, Pedro C
Publicado 2022

Single-dose (177)Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial

por Aggarwal, Rahul, Starzinski, Stephanie, de Kouchkovsky, Ivan, Koshkin, Vadim, Bose, Rohit, Chou, Jonathan, Desai, Arpita, Kwon, Daniel, Kaushal, Samuel, Trihy, Lauren, Rastogi, Medini, Ippisch, Robin, Aslam, Maya, Friedlander, Terence, Feng, Felix, Oh, David, Cheung, Alexander, Small, Eric, Evans, Michael, Fong, Lawrence, Hope, Thomas A
Publicado 2023

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer

por Jindal, Tanya, Zhu, Xiaolin, Bose, Rohit, Kumar, Vipul, Maldonado, Edward, Deshmukh, Prianka, Shipp, Chase, Feng, Stephanie, Johnson, Michelle S., Angelidakis, Austin, Kwon, Daniel, Borno, Hala T., de Kouchkovsky, Ivan, Desai, Arpita, Aggarwal, Rahul, Fong, Lawrence, Small, Eric J., Wong, Anthony, Porten, Sima, Chou, Jonathan, Friedlander, Terence, Koshkin, Vadim S.
Publicado 2023

TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor

por de Kouchkovsky, Ivan, Zhang, Li, Philip, Errol J, Wright, Francis, Kim, Daniel M, Natesan, Divya, Kwon, Daniel, Ho, Hansen, Ho, Son, Chan, Emily, Porten, Sima P, Wong, Anthony C, Desai, Arpita, Huang, Franklin W, Chou, Jonathan, Oh, David Y, Pruthi, Raj S, Fong, Lawrence, Small, Eric J, Friedlander, Terence W, Koshkin, Vadim S
Publicado 2021

APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer

por Natesan, Divya, Zhang, Li, Martell, Henry J., Jindal, Tanya, Devine, Patrick, Stohr, Bradley, Espinosa-Mendez, Carlos, Grenert, James, Van Ziffle, Jessica, Joseph, Nancy, Umetsu, Sarah, Onodera, Courtney, Turski, Michelle, Chan, Emily, Desai, Arpita, Aggarwal, Rahul, Wong, Anthony, Porten, Sima, Chou, Jonathan, Friedlander, Terence, Fong, Lawrence, Small, Eric J., Sweet-Cordero, Alejandro, Koshkin, Vadim S.
Publicado 2022